10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $525,649 | -29.3% | 12,743 | -4.3% | 0.00% | 0.0% |
Q2 2023 | $743,230 | +137.5% | 13,310 | +137.3% | 0.00% | 0.0% |
Q1 2023 | $312,926 | +75.9% | 5,609 | +14.9% | 0.00% | – |
Q4 2022 | $177,936 | -52.6% | 4,883 | -62.9% | 0.00% | -100.0% |
Q3 2022 | $375,000 | -42.9% | 13,172 | -9.2% | 0.00% | 0.0% |
Q2 2022 | $657,000 | -11.1% | 14,502 | +49.3% | 0.00% | 0.0% |
Q1 2022 | $739,000 | -28.7% | 9,711 | +39.6% | 0.00% | -50.0% |
Q4 2021 | $1,037,000 | +26.3% | 6,958 | +23.4% | 0.00% | 0.0% |
Q3 2021 | $821,000 | -20.1% | 5,640 | +7.6% | 0.00% | 0.0% |
Q2 2021 | $1,027,000 | +23.6% | 5,243 | +14.2% | 0.00% | 0.0% |
Q1 2021 | $831,000 | +2867.9% | 4,591 | +2195.5% | 0.00% | – |
Q4 2020 | $28,000 | +12.0% | 200 | 0.0% | 0.00% | – |
Q3 2020 | $25,000 | +38.9% | 200 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q1 2020 | $12,000 | -20.0% | 200 | 0.0% | 0.00% | – |
Q4 2019 | $15,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |